Navigation Links
Ruboxistaurin (RBX) may prevent vision loss in diabetic patients

Phase III clinical trial of Ruboxistaurin (RBX) at a concentration of 32 milligrams/day// was found to inhibit Protein kinase C (PKC) – beta inhibitor, which was found to cause vision loss in patients with diabetes.

The study was conducted in 252 patients with type 1 or type 2 diabetes by the Research team of Joslin Diabetes Centre across United States, Canada, Denmark, Netherlands and United Kingdom. The study was named as PKS-DRS, (Protein Kinase C – Diabetic Retinopathy Study), was done to evaluate the oral administration of RBX and placebo over a period of 3-4 years at a concentration of 8, 16 or 32 mg/day.

Incidence of eye complications is high in Diabetic patients, with common complications of diabetes causing diabetic retinopathy and diabetic macular edema. Diabetic retinopathy is characterised by damage to small blood vessels in the retina and causes severe vision loss. Diabetic macular edema is characterised by leaky blood vessels with swelling in the retina.

Protein kinase C is required for the normal production of energy in the body, but a-form of PKC has found to cause diabetic complications of the eye. a- PKC is the major signaling pathway which is stimulated by high blood glucose levels. In animal studies it was found that the abnormal activation of a-PKC decreases the blood flow to the retina.

The research team has found oral administration of 32 milligrams/day of Ruboxistaurin, blocks the activity of a-Protein kinase C. Moreover, RBX was found to be specific in binding only to the a-form of PKC. Though, RBX does not prevent the progression of diabetic retinopathy, it reduces the vision loss which is caused by macular edema. RBX in the study group did not produce any side-effects.
'"/>




Page: 1

Related medicine news :

1. Ruboxistaurin As A Novel Treatment For Diabetic Nephropathy
2. Asthma may actually be prevented by Dust and Dirt
3. Nearly all asthma deaths preventable
4. Breast Feeding prevents obesity later on in life
5. Regular exercise prevents hip fractures
6. Gel prevents pregnancy
7. Arterial stiffness prevented by light drinking
8. How to prevent wrinkles?
9. Re-blockage of heart arteries prevented by vitamins
10. Early delivery can prevent cancer
11. Hobbies prevent dementia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at global ... is recognized globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, ... move to sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice ...
(Date:1/21/2017)... Pekin, IL (PRWEB) , ... January 21, 2017 , ... ... disorders. Even when individuals experience the freedom of recovery, they often feel shame for ... abuse and post-traumatic stress disorder (PTSD). In the workshop, “Rising Strong in Life After ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and ... essential oils, announced the company had a successful visit to the 2017 ECRM Diet, ... gives companies that work in the nutritional, sports and health industries a chance to ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out ... announced it attended the January ECRM trade show in Hilton Head, SC. , ... was determined to create a line of products that would elevate her fitness regime. ...
(Date:1/20/2017)... ... ... “The Angel”: a heartwarming and earnest tale of faith and believing in the ... is the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of ... asked of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)...  Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage ... announced new additions to its senior leadership team: ... and Daniel Geffken as interim Chief Financial ... , Pharm.D. has been promoted to Chief Clinical Development ... Doug and Daniel to our management team, as both ...
Breaking Medicine Technology: